The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT00107120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind Flexible Dose Study of Escitalopram in Pediatric Patients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Depression affects approximately 2.5% of children and 8% of adolescents. Escitalopram is the S-enantiomer of citalopram. Both escitalopram and citalopram are selective serotonin reuptake inhibitors (SSRIs) and are used to treat depression in adults. This study is designed to provide a systematic evaluation of the safety and efficacy of escitalopram in the treatment of depressed pediatric patients, 12 to 17 years of age. Patients completing the study will be eligible to enter an open-label extension study.
Study identification
- NCT ID
- NCT00107120
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 312 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2005 (Type not available)
- Primary completion
- May 2007 (Actual)
- Completion
- Not listed
- Last update posted
- Apr 6, 2012
Started 2005
United States locations
- U.S. sites
- 28
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California at Davis, MIND Institute, Health Services | Sacramento | California | 95817 | — |
| UCSD Outpatient Psychiatry Services | San Diego | California | 92103 | — |
| PCSD - Feighner Research | San Diego | California | 92111 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| University of Florida - Child Study Program | Gainesville | Florida | 32610 | — |
| Clinical Neuroscience Solutions, Inc. | Jacksonville | Florida | 32216 | — |
| Janus Center for Psychiatric Research | West Palm Beach | Florida | 33407 | — |
| Kolin Research Group | Winter Park | Florida | 32789 | — |
| Capstone Clinical Research | Libertyville | Illinois | 60048 | — |
| Clinco | Terre Haute | Indiana | 47802 | — |
| Psychiatric Associates | Overland | Kansas | 66211 | — |
| Pharmasite Research, Inc. | Baltimore | Maryland | 21208 | — |
| Capitol Clinical Research Associates | Rockville | Maryland | 20852 | — |
| St. Charles Psychiatric Associates | Saint Charles | Missouri | 63301 | — |
| Creighton University Medical School, Department of Psychiatry | Omaha | Nebraska | 68131 | — |
| CNS Research Institute | Clementon | New Jersey | 08021 | — |
| Pulmonary and Allergy Associates, P. A. | Summit | New Jersey | 07901 | — |
| North Carolina Neuropsychiatry, PA | Chapel Hill | North Carolina | 27514 | — |
| University of Cincinnati College of Medicine, Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | — |
| University Hospitals of Cleveland, Division of Child & Adolescent Psychiatry | Cleveland | Ohio | 44106 | — |
| IPS Research Company | Oklahoma City | Oklahoma | 73103 | — |
| University of Pennsylvania, Department of Psychiatry, Mood & Anxiety Disorders Section | Philadelphia | Pennsylvania | 19104 | — |
| Drexel University College of Medicine, Friends Hospital | Philadelphia | Pennsylvania | 19124 | — |
| Clinical Neuroscience Solutions | Memphis | Tennessee | 38119 | — |
| University of Texas Southwestern Medical Center, Center for Pediatric Psychiatry | Dallas | Texas | 75235 | — |
| University of Texas Medical Branch, Department of Psychiatry & Behavioral Sciences | Galveston | Texas | 77555 | — |
| Brighton Research Group, LLC | Virginia Beach | Virginia | 23452 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00107120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2012 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00107120 live on ClinicalTrials.gov.